|15th January 2021||Bob Rosenthal||4,281||Grant/award etc.||$6.63||$28,378.32|
|13th January 2021||Bonnie H Anderson||12,177||Open or private sale||$51.26||$624,179.63|
|13th January 2021||Bonnie H Anderson||6,364||Open or private sale||$50.64||$322,282.51|
|13th January 2021||Bonnie H Anderson||18,541||Exercise of derivative||$5.61||$104,015.01|
|7th January 2021||Marc A Kastner||1,236||Open or private sale||$56.56||$69,908.16|
|5th January 2021||Bonnie H Anderson||2,302||Grant/award etc.||$0.00|
|5th January 2021||Cynthia M Friend||2,302||Grant/award etc.||$0.00|
|5th January 2021||Richard A Packer||2,302||Grant/award etc.||$0.00|
|5th January 2021||Bob Rosenthal||2,302||Grant/award etc.||$0.00|
|5th January 2021||Marc A Kastner||2,302||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.
Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of Bruker BioSpin Group, Bruker CALID Group, and the Brukers Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors.